1. Which of the following patients is presenting with stress-induced short-term insomnia?

2. Which of the following groups experienced the most impact on sleep due to the COVID-19 pandemic?

3. KS is a 20-year-old male presenting to the community pharmacy for a recommendation. He recently quit smoking marijuana and has since been having trouble falling asleep. Which of the following is the best recommendation for KS?

4. DB is a 68-year-old female presenting to the community pharmacy requesting a recommendation from the pharmacist. DB has glaucoma, hypertension, and heart failure with preserved ejection fraction. She has been experiencing trouble falling asleep 3 times a week for the last month. Which of the following treatments is the best choice to recommend?

5. Which of the following antihistamines has a Food and Drug Administration (FDA) indication as a nighttime sleep aid?

6. A patient approaches the community pharmacy with 2 bottles of melatonin from two different manufacturers. Only 1 bottle contains the USP seal of approval. You recommend the melatonin bottle containing the USP seal of approval. Why?

7. Which of the following counseling points should be included when discussing diphenhydramine?

8. Which of the following is an appropriate sleep hygiene recommendation?

9. Which statement concerning the use of melatonin or valerian for the treatment of insomnia is true?

10. A 37-year-old female comes to the pharmacy to ask for your assistance in selecting a “natural product” to help with her short-term insomnia. She has no exclusions for self-care, does not want to take melatonin as it has not worked for her in the past, and is opposed to prescription and nonprescription drugs. Which plan would you suggest?

Evaluation Questions

11. How confident are in your treatment choice for KS in question #3?

12. How confident are in your treatment choice for DB in question #4?

13. How confident are in your treatment choices for the 37-year-old patient in question #10?

« Return to Activity